Edited by Menéndez González, M., M-Y Books, 2011, ISBN: 978-1-44772-356-1 The search of methods to ease the diag-nosis of Alzheimer’s disease (AD) as early as possible is in the center of attention. Such methods (biomarkers) are a range of blood or CSF tests on one hand, and several types of neuroimaging scans on the other. Biomarkers are going to be included not only in the neuroscience research area but also in the diagnosis process with a practical application in the next years. The potential for these biomarkers to serve diagnostic purposes of AD has been highlighted in the pro-posed diagnostic criteria for preclinica
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsycholo...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers o...
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, and it is characterized...
Alzheimer’s disease (AD) represents a major public health concern and has been identified as a resea...
Martina Zvěřová1,2 1Department of Psychiatry, General University Hospital in Prague, Prague,...
Alzheimer disease (AD) is a neurodegenerative disorder characterized by significant cognitive defici...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
An estimated 6.1 million Americans live with cognitive impairment—a number that is expected to tripl...
Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting f...
Alzheimer’s disease (AD) is the most common neurodegenerative disease among the elderly, affecting m...
OBJECTIVE: To present the ongoing researches for biomarkers in Alzheimer disease METHODS: Bibliograp...
Biomarker discovery and development for clinical research, diagnostics and therapy monitoring in cli...
Alzheimer's disease (AD) is a slowly progressing non-linear dynamic brain disease in which pathophys...
Alzheimer’s disease, the most prevalent type of dementia, affects the life of elderly, to such exten...
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsycholo...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers o...
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, and it is characterized...
Alzheimer’s disease (AD) represents a major public health concern and has been identified as a resea...
Martina Zvěřová1,2 1Department of Psychiatry, General University Hospital in Prague, Prague,...
Alzheimer disease (AD) is a neurodegenerative disorder characterized by significant cognitive defici...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
An estimated 6.1 million Americans live with cognitive impairment—a number that is expected to tripl...
Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting f...
Alzheimer’s disease (AD) is the most common neurodegenerative disease among the elderly, affecting m...
OBJECTIVE: To present the ongoing researches for biomarkers in Alzheimer disease METHODS: Bibliograp...
Biomarker discovery and development for clinical research, diagnostics and therapy monitoring in cli...
Alzheimer's disease (AD) is a slowly progressing non-linear dynamic brain disease in which pathophys...
Alzheimer’s disease, the most prevalent type of dementia, affects the life of elderly, to such exten...
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsycholo...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers o...